Skip to main content

Table 1 Demographics of the study cohort

From: Angiotensin-converting enzyme 2 is reduced in Alzheimer’s disease in association with increasing amyloid-β and tau pathology

  Control (n = 59) AD (n = 90)
Age, years, mean ± SD 78.5 ± 10.1 78.5 ± 9.7
Sex, F/M 22/37 55/35
PM delay, h, mean ± SD) 43.8 ± 36.4 45.2 ± 25.1
  1. AD Alzheimer’s disease, PM Post-mortem